Buruli ulcer historical perspective

Jump to: navigation, search

Buruli ulcer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Buruli ulcer from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Buruli ulcer historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Buruli ulcer historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Buruli ulcer historical perspective

CDC on Buruli ulcer historical perspective

Buruli ulcer historical perspective in the news

Blogs on Buruli ulcer historical perspective

Directions to Hospitals Treating Buruli ulcer

Risk calculators and risk factors for Buruli ulcer historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Buruli ulcer was first described in 1948 from the Bairnsdale district in south-east Australia.

Historical Perspective

The disease was well known in Africa before this time but the mycobacterium had never been identified. James Augustus Grant, in his book A Walk across Africa, describes how his leg became grossly swollen and stiff with later a copious discharge. This was almost certainly the severe oedematous form of the disease, and is the first known description of the infection. The name "Buruli ulcer" comes from an area in Uganda where the disease was once most prevalent, especially during the 1960s.

Just recently, an international team of researchers led by Monash University scientist Dr Tim Stinear has unlocked the entire genomic makeup of this mysterious disease hoping it could provide researchers with the knowledge of creating a treatment or even a vaccine.

References




Linked-in.jpg